Skip to main content
    U

    Upstream Bio, Inc. (UPB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.15
    -0.63 (-22.66%)

    Market Cap: $152.38M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Upstream Bio, Inc. (UPB) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Upstream Bio (UPB) is expected to report earnings on Mar 24, 2027. In the quarter ended Sep 30, 2026, Upstream Bio reported EPS of -$0.75, below the -$0.67 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    33%(3/9)
    Avg Surprise
    -10.21%

    Upcoming Estimates

    Reports Mar 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.72
    Range-$0.93 - -$0.44
    8 analysts
    Revenue Consensus
    $431.27K
    RangeN/A
    8 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.79
    Range-$1.03 - -$0.61
    4 analysts
    EPS Revisions
    2
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.88+10.0%
    60d ago-$0.77-2.3%
    30d ago-$0.77-2.3%
    7d ago-$0.77-2.3%
    Current-$0.79
    Revenue Consensus
    $135.67K
    RangeN/A
    3 analysts

    Next Report

    UPB has an expected report date of Mar 24, 2027.

    Earnings History

    Of the 9 quarters below that had an estimate, UPB beat 3, missed 5 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $395000, down 42.2% from $683000 a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.75-$0.67-$0.88 - -$0.52-11.94%MissN/A84 up, 3 downNov 10, 2026$395000
    Jun 30, 2026-$0.73-$0.78-$0.87 - -$0.62+6.41%BeatN/A92 up, 5 downAug 11, 2026$773000
    Mar 31, 2026-$0.75-$0.75-$0.89 - -$0.640.00%In lineN/A81 up, 2 downMay 13, 2026$1.03M
    Dec 31, 2025-$0.78-$0.70-$0.70 - -$0.65-11.43%MissN/A31 up, 0 downMar 26, 2026$668000
    Sep 30, 2025-$0.63-$0.78-$0.85 - -$0.67+19.23%BeatN/A51 up, 2 downNov 5, 2025$683000
    Jun 30, 2025-$0.74-$0.61N/A-21.31%MissN/AN/AN/AAug 6, 2025$937000
    Mar 31, 2025-$0.51-$0.48-$0.59 - -$0.40-6.25%MissN/A40 up, 0 downMay 6, 2025$566000
    Dec 31, 2024-$0.41-$0.54-$0.77 - -$0.39+24.12%BeatN/A4N/AMar 13, 2025$613000
    Sep 30, 2024-$6.96-$3.65N/A-90.68%MissN/AN/AN/AOct 11, 2024$607000
    Jun 30, 2024-$11.18N/AN/AN/AN/AN/AN/AN/AAug 28, 2024$510000
    Last 10 quarters

    Annual EPS

    Fiscal year endedEPSChange
    Sep 30, 2026-$2.23N/A
    Jun 30, 2026-$1.48N/A
    Dec 31, 2025-$2.66N/A
    Dec 31, 2024-$18.55N/A

    Frequently Asked Questions About UPB

    When is Upstream Bio's next earnings date?

    Upstream Bio's next earnings report is expected for Mar 24, 2027.

    Did UPB beat earnings estimates last quarter?

    No. Upstream Bio reported EPS of -$0.75 for the quarter ended Sep 30, 2026, below the -$0.67 estimate by 11.94%.

    What EPS do analysts expect from UPB next quarter?

    The consensus EPS estimate for Upstream Bio for the quarter ending Dec 31, 2026 is -$0.72 from 8 analysts, with estimates from -$0.93 to -$0.44.

    How often does UPB beat earnings estimates?

    Upstream Bio beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -0.15%.